Cargando…
Subtrochanteric Femoral Insufficiency Fracture Following Bisphosphonate Therapy for Osseous Metastases
We present the case of an insufficiency fracture of the femoral shaft in a 61-year-old man who had received bisphosphonate therapy to reduce the fracture risk from lytic renal cell carcinoma metastases to the spine. Approximately 1.5 years after beginning monthly intravenous infusions of zoledronic...
Autores principales: | Bush, Lisabeth A., Chew, Felix S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897555/ https://www.ncbi.nlm.nih.gov/pubmed/27303562 http://dx.doi.org/10.2484/rcr.v3i4.232 |
Ejemplares similares
-
Subtrochanteric Femoral Insufficiency Fracture in Woman on Bisphosphonate Therapy for Glucocorticoid-Induced Osteoporosis
por: Bush, Lisabeth A., et al.
Publicado: (2016) -
Bisphosphonates and atypical subtrochanteric fractures of the femur
por: Kharwadkar, N., et al.
Publicado: (2017) -
Is Full-Length Intramedullary Nail Necessary for Atypical Subtrochanteric Femoral Fracture Associated with Bisphosphonate?
por: Kim, Kwang-kyoun, et al.
Publicado: (2020) -
Do bisphosphonates cause femoral insufficiency fractures?
por: Seraphim, Andreas, et al.
Publicado: (2012) -
Femoral insufficiency fracture related to bisphosphonate use
por: Choudry, Misha S., et al.
Publicado: (2023)